STOCK TITAN

AMETEK INC/ (AME) SEC Filings, Feb-Mar 2026

AME NYSE

AMETEK, Inc. filings document regulatory disclosures for a NYSE-listed industrial technology company with common stock registered under Section 12(b). Recent Form 8-K reports cover operating results, dividend actions, acquisition-related material events, board appointments, officer transitions and shareholder voting matters.

Proxy materials and annual meeting disclosures address director elections, executive compensation, auditor ratification and other governance matters. AMETEK's filings also describe capital-structure information, material-event exhibits and business reporting for its Electronic Instruments and Electromechanical operations.

Rhea-AI Summary

AMATO THOMAS A reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Thomas A. Amato received a grant of 950 shares of restricted common stock, valued at $212.77 per share, under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related award rather than an open-market purchase.

After the grant, he directly holds 5,010 common shares. The filing also shows an additional 6,500 common shares held indirectly by a trust, giving him both direct and indirect exposure to AMETEK stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. director Stefany Suzanne received a grant of 950 shares of Common Stock as a restricted stock award. The award was issued at a value of $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this compensation-related acquisition, she directly holds 5,030 AMETEK shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK Inc. director Dean Seavers reported an equity award of company stock. On this Form 4, he acquired 950 shares of AMETEK common stock as a grant or award valued at $212.77 per share. The shares constitute restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.

Following this award, Seavers directly holds 5,600 shares of AMETEK common stock. This transaction reflects compensation in stock rather than an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AMETEK director Anthony James Conti received a grant of company stock as compensation. He acquired 950 shares of AMETEK common stock on March 18, 2026, recorded at $212.77 per share, as restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. Following this award, he directly owns 30,298 common shares. This was a compensation-related grant, not an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carpenter Tod E. reported acquisition or exercise transactions in this Form 4 filing.

AMETEK director Tod E. Carpenter received a grant of 950 shares of common stock, valued at $212.77 per share, as equity compensation. The award is restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan and is held directly.

After this grant, Carpenter directly owns 10,480 AMETEK common shares. Restricted stock generally vests over time or upon meeting conditions, aligning a director’s interests with long-term shareholder value rather than representing an open-market purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

AMETEK director Gretchen W. McClain received 950 shares of common stock as a restricted stock award at $212.77 per share under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. This is a compensation-related grant, not an open‑market purchase.

McClain now holds 18,981 shares of common stock directly after this award. She also acquired 52 additional common stock units through dividend reinvestments in the Deferred Compensation Plan, bringing her deferred compensation holdings to 3,199 units. These transactions reflect routine equity compensation and plan reinvestments rather than discretionary trading.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
-
Rhea-AI Summary

AMETEK, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on May 7, 2026. Holders of 229,065,429 shares of common stock as of March 9, 2026 may vote on three proposals: electing three Class II directors, an advisory “say‑on‑pay” vote, and ratifying Ernst & Young LLP as independent auditor for 2026.

The Board is largely independent, uses majority voting in uncontested director elections, and highlights strong historic support for its pay and audit practices, with about 94% average approval on executive compensation over the past decade and 93% support for Ernst & Young in the prior year. Non‑employee directors receive a mix of cash retainers and restricted stock, with increases to retainers and equity awards scheduled for 2026, and equity-based, performance‑linked incentives are emphasized for executives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

AMETEK director Thomas A. Amato reported two Form 4 “other” transactions (code J) involving 6,500 shares of common stock each at a stated price of $0.00 per share. After these entries, he holds 4,060 shares directly and 6,500 shares indirectly through a trust where he serves as trustee.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

AMETEK Senior VP and Controller Robert Amodei reported routine equity compensation activity. He acquired 279 shares of common stock at $0.0000 per share as a grant, reflecting the settlement of PRSUs awarded on March 22, 2023. To cover related tax obligations, 96 shares were disposed of at $233.3300 per share through a tax-withholding transaction. After these transactions, he directly held 43,930 shares of common stock, along with 711 common stock/Serp units and 3,149 shares held indirectly through a 401(k) plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many AMETEK INC/ (AME) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for AMETEK INC/ (AME), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMETEK INC/ (AME)?

The most recent SEC filing for AMETEK INC/ (AME) was filed on March 18, 2026.